Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -5.1x - -5.7x | -5.4x |
| Selected Fwd P/E Multiple | -4.9x - -5.4x | -5.2x |
| Fair Value | A$0.37 - A$0.41 | A$0.39 |
| Upside | -7.9% - 1.8% | -3.0% |
| Benchmarks | - | Full Ticker |
| Paragon Care Limited | - | ASX:PGC |
| Microba Life Sciences Limited | - | ASX:MAP |
| Rhythm Biosciences Limited | - | ASX:RHY |
| Healius Limited | - | ASX:HLS |
| Integral Diagnostics Limited | - | ASX:IDX |
| INOVIQ Ltd | - | ASX:IIQ |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| PGC | MAP | RHY | HLS | IDX | IIQ | |||
| ASX:PGC | ASX:MAP | ASX:RHY | ASX:HLS | ASX:IDX | ASX:IIQ | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 32.9% | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | 21.0% | NM- | NM- | NM- | NM- | NM- | ||
| Latest Twelve Months | NM | 23.2% | 74.8% | 11.5% | 109.8% | -5.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 0.4% | -219.0% | -570.1% | -10.1% | 2.6% | -659.5% | ||
| Prior Fiscal Year | 0.6% | -233.9% | -265.4% | -36.4% | 5.7% | -419.7% | ||
| Latest Fiscal Year | 0.3% | -164.9% | -405.7% | -41.9% | -12.9% | -381.9% | ||
| Latest Twelve Months | 0.4% | -84.0% | -68.7% | -41.9% | 1.2% | -381.9% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 15.7x | -2.2x | -11.6x | 49.2x | 22.9x | -6.3x | ||
| Price / LTM Sales | 0.2x | 3.2x | 8.8x | 0.5x | 2.3x | 24.6x | ||
| LTM P/E Ratio | 45.7x | -3.9x | -12.8x | -1.2x | 200.5x | -6.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -12.8x | -1.2x | 200.5x | |||||
| Historical LTM P/E Ratio | -18.7x | -6.4x | -2.5x | |||||
| Selected P/E Multiple | -5.1x | -5.4x | -5.7x | |||||
| (x) LTM Net Income | (7) | (7) | (7) | |||||
| (=) Equity Value | 36 | 37 | 39 | |||||
| (/) Shares Outstanding | 111.6 | 111.6 | 111.6 | |||||
| Implied Value Range | 0.32 | 0.34 | 0.35 | |||||
| FX Rate: AUD/AUD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 0.32 | 0.34 | 0.35 | 0.40 | ||||
| Upside / (Downside) | -20.2% | -16.0% | -11.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | PGC | MAP | RHY | HLS | IDX | IIQ | |
| Value of Common Equity | 662 | 48 | 28 | 679 | 1,135 | 45 | |
| (/) Shares Outstanding | 1,655.3 | 515.0 | 284.1 | 726.1 | 372.2 | 111.6 | |
| Implied Stock Price | 0.40 | 0.09 | 0.10 | 0.94 | 3.05 | 0.40 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 0.40 | 0.09 | 0.10 | 0.94 | 3.05 | 0.40 | |
| Trading Currency | AUD | AUD | AUD | AUD | AUD | AUD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |